Urogenital Cancer Epidemiology in Poland (1980-2020): A Narrative Review

Overview

Journal Cancers (Basel)

Publisher MDPI

Date 2025 Jan 25

PMID 39858098

Authors

Iwona Wnetrzak

Joanna Didkowska

Roman Sosnowski

Mateusz Czajkowski

Dawid Sigorski

Bartosz Malkiewicz

Piotr Marczynski

Jaroslaw Jaskulski

Piotr Kania

Adam Ostrowski

Artur Sieczych

Grzegorz Kade

Piotr Purpurowicz

Stanislaw Szemplinski

Robert Nowakowski

Affiliations

Soon will be listed here.

Abstract

Despite advances in prophylaxis, early diagnosis, and treatment, urogenital cancers represent a significant challenge to public health in Poland due to their relatively high prevalence and mortality rates. This narrative review aims to explore contemporary evidence on the epidemiology of urogenital cancers in Poland, such as prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer, focusing on current and historical status and trends in the broader context of healthcare delivery. The literature consistently indicates that urogenital cancer continues to be a significant contributor to cancer incidence and mortality rates in Poland. Although the body of evidence is expanding, its quantity remains limited, primarily attributable to the scarcity of top-notch epidemiological investigations targeting particular forms of cancer, such as testicular and penile cancers, which are characterized by sporadic occurrences.

References

Czaderny K . High prostate cancer mortality in Poland. A spatial, temporal and structural analysis. Przegl Epidemiol. 2018; 72(2):235-246. View

Jobczyk M, Pikala M, Rozanski W, Maniecka-Bryla I . Years of life lost due to bladder cancer among the inhabitants of Poland in the years 2000 to 2014. Cent European J Urol. 2018; 70(4):338-343. PMC: 5791403. DOI: 10.5173/ceju.2017.1521. View

Ryszawy J, Kowalik M, Wojnarowicz J, Rempega G, Kepinski M, Burzynski B . Awareness of testicular cancer among adult Polish men and their tendency for prophylactic self-examination: conclusions from Movember 2020 event. BMC Urol. 2022; 22(1):149. PMC: 9469579. DOI: 10.1186/s12894-022-01098-1. View

Choreza P, Owczarek A, Kruk W, Chudek J . The epidemiology of the most frequent cancers in Poland in 2015-2021 and the impact of the COVID-19 pandemic on cancer incidence. Arch Public Health. 2024; 82(1):49. PMC: 11021004. DOI: 10.1186/s13690-024-01277-6. View

Jankowski M, Ostrowska A, Sierpinski R, Skowron A, Sytnik-Czetwertynski J, Giermaziak W . The Prevalence of Tobacco, Heated Tobacco, and E-Cigarette Use in Poland: A 2022 Web-Based Cross-Sectional Survey. Int J Environ Res Public Health. 2022; 19(8). PMC: 9031359. DOI: 10.3390/ijerph19084904. View

Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M . The Waiting Time of Prostate Cancer Patients in Poland. Int J Environ Res Public Health. 2019; 16(3). PMC: 6388381. DOI: 10.3390/ijerph16030342. View

Gliniewicz A, Dudek-Godeau D, Bielska-Lasota M . Survival in men diagnosed with prostate cancer in Poland in the years 2000 - 2014 compared to European Countries based on Concord-3. Rocz Panstw Zakl Hig. 2020; 71(4):445-453. DOI: 10.32394/rpzh.2020.0143. View

Pepe P, Panella P, Savoca F, Cacciola A, DArrigo L, Dibenedetto G . Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (< or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%. Urol Int. 2007; 78(4):308-12. DOI: 10.1159/000100833. View

Yazici S, Biondo D, Napodano G, Grillo M, Calace F, Prezioso D . Risk Factors for Testicular Cancer: Environment, Genes and Infections-Is It All?. Medicina (Kaunas). 2023; 59(4). PMC: 10145700. DOI: 10.3390/medicina59040724. View

10.

Aragona F, Pepe P, Motta M, Saita A, Raciti G, La Rosa P . Incidence of prostate cancer in Sicily: results of a multicenter case-findings protocol. Eur Urol. 2005; 47(5):569-74. DOI: 10.1016/j.eururo.2004.11.007. View

11.

Bergengren O, Pekala K, Matsoukas K, Fainberg J, Mungovan S, Bratt O . 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. Eur Urol. 2023; 84(2):191-206. PMC: 10851915. DOI: 10.1016/j.eururo.2023.04.021. View

12.

Jubber I, Ong S, Bukavina L, Black P, Comperat E, Kamat A . Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur Urol. 2023; 84(2):176-190. DOI: 10.1016/j.eururo.2023.03.029. View

13.

Verhoeven R, Janssen-Heijnen M, Saum K, Zanetti R, Caldarella A, Holleczek B . Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer. 2012; 49(6):1414-21. DOI: 10.1016/j.ejca.2012.10.029. View

14.

Moczeniat G, Jankowski M, Duda-Zalewska A, Gujski M . Awareness of Genitourinary Cancers Risk Factors-A 2024 Population-Based Cross-Sectional Study in Poland. Int J Public Health. 2024; 69:1607264. PMC: 11224143. DOI: 10.3389/ijph.2024.1607264. View

15.

Wnetrzak I, Czajkowski M, Baranska K, Miklewska M, Wojciechowska U, Sosnowski R . Epidemiology of penile cancer in Poland compared to other European countries. Cancer Med. 2024; 13(16):e70092. PMC: 11335812. DOI: 10.1002/cam4.70092. View

16.

Wong M, Goggins W, Wang H, Fung F, Leung C, Wong S . Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol. 2016; 70(5):862-874. DOI: 10.1016/j.eururo.2016.05.043. View

17.

Maule M, Malavassi J, Richiardi L . Age at puberty and risk of testicular cancer: a meta-analysis. Int J Androl. 2012; 35(6):828-834. DOI: 10.1111/j.1365-2605.2012.01286.x. View

18.

Pikala M, Burzyn Ska M, Pikala R, Bryla M, Maniecka-Bryla I . Educational inequalities in premature mortality in Poland, 2002-2011: a population-based cross-sectional study. BMJ Open. 2016; 6(9):e011501. PMC: 5051391. DOI: 10.1136/bmjopen-2016-011501. View

19.

Capitanio U, Bensalah K, Bex A, Boorjian S, Bray F, Coleman J . Epidemiology of Renal Cell Carcinoma. Eur Urol. 2018; 75(1):74-84. PMC: 8397918. DOI: 10.1016/j.eururo.2018.08.036. View

20.

Sosnowski R, Wolski J, Zi Talewicz U, Szyma Ski M, Baku A R, Demkow T . Assessment of selected quality of life domains in patients who have undergone conservative or radical surgical treatment for penile cancer: an observational study. Sex Health. 2018; 16(1):32-38. DOI: 10.1071/SH17119. View